Inventor · disambiguated record
Garry Fenton
Also filed as: FENTON GARRY
29 granted patents·7 pending applications·439 citations·filing 1982–2010
97Inventor score
Files withASTERAND UK LTD10AVENTIS PHARMA LTD8RHONE POULENC RORER LTD5MAY & BAKER LTD4BAESCHLIN DANIEL KASPAR3
Top patents by PatentIndex Score
36 records- 0194US5935978ACompounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking groupRHONE POULENC RORER LTD·Filed 1993·Granted Aug 10, 1999·71 cites·36 claims
- 0292US5679696ACompounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking groupRHONE POULENC RORER LTD·Filed 1995·Granted Oct 21, 1997·73 cites·27 claims
- 0391US7326732B2EP2 receptor agonistsPHARMAGENE LAB LTD·Filed 2005·Granted Feb 5, 2008·18 cites·8 claims
- 0490US7211586B2Substituted tetrahydroisoquinolinesAVENTIS PHARMA LTD·Filed 2003·Granted May 1, 2007·41 cites·22 claims
- 0589US7803841B2EP2 receptor agonistsASTERAND UK LTD·Filed 2008·Granted Sep 28, 2010·11 cites·13 claims
- 0688US7652144B2Compounds as PDE IV and TNF inhibitorsAVENTIS PHARMA LTD·Filed 2007·Granted Jan 26, 2010·7 cites·8 claims
- 0788US6255326B1Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking groupAVENTIS PHARMA LTD·Filed 1999·Granted Jul 3, 2001·36 cites·22 claims
- 0888US5840724ACompounds containing phenyl linked to aryl or heteroaryl by an aliphatic- orRHONE POULENC RORER LTD·Filed 1997·Granted Nov 24, 1998·40 cites·20 claims
- 0986US7662839B2EP2 receptor agonistsASTERAND UK LTD·Filed 2007·Granted Feb 16, 2010·7 cites·15 claims
- 1085US6096768ACompounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking groupRHONE POULENC RORER LTD·Filed 1999·Granted Aug 1, 2000·32 cites·6 claims
- 1184US7528157B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2006·Granted May 5, 2009·3 cites·24 claims
- 1284US7507754B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2007·Granted Mar 24, 2009·3 cites·41 claims
- 1382US8129537B2Compounds as PDE IV and TNF inhibitorsFENTON GARRY·Filed 2010·Granted Mar 6, 2012·7 cites·30 claims
- 1481US7196089B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Mar 27, 2007·8 cites·30 claims
- 1581US7045660B2Compounds as PDE IV and TNF-inhibitorsAVENTIS PHARMA LTD·Filed 2004·Granted May 16, 2006·9 cites·27 claims
- 1677US7417068B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 26, 2008·8 cites·15 claims
- 1775US7569602B2Furan derivatives as EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 4, 2009·6 cites·13 claims
- 1873US8080567B2EP2 receptor agonistsOXFORD ALEXANDER WILLIAM·Filed 2006·Granted Dec 20, 2011·2 cites·21 claims
- 1971US7888351B2Organic compoundsNOVARTIS AG·Filed 2007·Granted Feb 15, 2011·1 cites·14 claims
- 2071US7166616B2Substituted alkanoic acidsAVENTIS PHARMA LTD·Filed 2003·Granted Jan 23, 2007·5 cites·19 claims
- 2168US7858644B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2009·Granted Dec 28, 2010·0 cites·23 claims
- 2265US6472412B1Compounds as PDE IV and TNF inhibitorsAVENTIS PHARMA LTD·Filed 1996·Granted Oct 29, 2002·14 cites·33 claims
- 2363US5541219A1-Alkoxy-2-(alkoxy- or cycloalkoxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-) benzenes as inhibitors of cyclic AMP phosphodiesterase and tumor necrosis factorRHONE POULENC RORER LTD·Filed 1993·Granted Jul 30, 1996·15 cites·23 claims
- 2461US2008306117A1Ep4 receptor antagonistsASTERAND UK LTD·Filed 2008·Application pending·0 cites
- 2560US2006084809A1Compounds as PDE IV and TNF-inhibitorsAVENTIS PHARMA LTD·Filed 2005·Application pending·0 cites
- 2657US4493843AIndole and indoline carboxylic acid compounds and method of useMAY & BAKER LTD·Filed 1982·Granted Jan 15, 1985·4 cites·34 claims
- 2754US2003013713A1Compounds as PDE IV and TNF-inhibitorsFiled 2002·Application pending·0 cites
- 2853US5004747AIsoquinolinonesMAY & BAKER LTD·Filed 1990·Granted Apr 2, 1991·14 cites·17 claims
- 2952US2010261760A1EP2 Receptor AgonistsASTERAND UK LTD·Filed 2010·Application pending·0 cites
- 3050US7902224B2Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulatorsGLAXO GROUP LTD·Filed 2005·Granted Mar 8, 2011·0 cites·20 claims
- 3141US2013012485A1Organic compoundsBAESCHLIN DANIEL KASPAR·Filed 2007·Application pending·0 cites
- 3239US4960775APyrrolophthalazinesMAY & BAKER LTD·Filed 1988·Granted Oct 2, 1990·3 cites·16 claims
- 3338US6762199B2Indane derivativesAVENTIS PHARMA LTD·Filed 2002·Granted Jul 13, 2004·0 cites·19 claims
- 3437US2011034462A1Organic compoundsBAESCHLIN DANIEL KASPAR·Filed 2010·Application pending·0 cites
- 3535US2009192138A1compoundsBAESCHLIN DANIEL KASPAR·Filed 2006·Application pending·0 cites
- 3630US4933350APyrroloisoquinolines useful as hypercholesterolemic and hyperlipoprotienimic agentsMAY & BAKER LTD·Filed 1988·Granted Jun 12, 1990·1 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →